Target intelligence / Profile preview

Ankyrin repeat domain 33B pseudogene 5 (ANKRD33BP5)

Target
ANKRD33BP5
Molecular classification
Other (Pseudogene), Long non-coding RNA (lncRNA)
01

Overview

Ankyrin repeat domain 33B pseudogene 5 (ANKRD33BP5) is a non-coding genomic DNA element classified as a pseudogene, meaning it is a segment of DNA that resembles a functional gene but usually does not encode a functional protein[3][5]. Pseudogenes are often the result of gene duplication or retrotransposition but lose coding function through mutations. Some pseudogenes, especially those transcribed into RNA, may participate in regulatory roles, such as acting as competing endogenous RNAs (ceRNAs) that interact with microRNAs and influence the expression of other genes[6]. However, there is no evidence that ANKRD33BP5 encodes a functional protein or serves directly as a therapeutic target in any disease context. Most genomic databases list it as a pseudogene without established biological function, clinical significance, or direct pharmacological relevance[3][5][6]. Ankyrin repeat domain 33B pseudogene 5 is a non-coding pseudogene with no established protein product or direct therapeutic relevance; pseudogenes can participate in RNA regulatory networks but ANKRD33BP5 has no specific or validated biological or clinical function.

Other names
ANKRD33BP5ANKRD33B Pseudogene 5
02

Biological functions

Potential to function as a competing endogenous RNA (ceRNA) or RNA sponge for microRNAsMay participate indirectly in gene regulation through non-coding RNA networksPotential ceRNA (microRNA sponge)gene regulation (putative)
03

Disease associations

Other (pseudogenes can be involved in regulatory networks related to cancer, but no direct role is established for ANKRD33BP5 specifically)Other (regulatory roles in cancer have been described for other pseudogenes, but not specifically for this one)

Beyond the preview

Go deeper on Ankyrin repeat domain 33B pseudogene 5 (ANKRD33BP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 33B pseudogene 5 (ANKRD33BP5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call